| |
| |
|
| Insider
Information: |
Santiago Karen Murphy |
| Relationship: |
VP & Chief Accounting ... |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
21,467 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,015,521 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,467 |
|
|
| Total
Value |
$1,015,521 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 17.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
SVP & Controller |
2022-03-14 |
16,704 |
2018-03-10 |
0 |
Premium* |
|
|
Catalent, Inc. |
CTLT |
VP & Chief Accounting ... |
2023-08-01 |
4,763 |
2022-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTLT |
Catalent, Inc. |
VP & Chief Accounting Officer |
• – – |
2023-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,342 |
4,763 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
VP & Chief Accounting Officer |
• – – |
2022-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,421 |
2,421 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2022-03-14 |
4 |
S |
$69.20 |
$455,096 |
D/D |
(6,577) |
16,704 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2022-03-10 |
4 |
D |
$68.42 |
$425,778 |
D/D |
(6,223) |
23,281 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,933 |
27,781 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,073 |
24,489 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2021-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,069 |
15,045 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2021-07-01 |
4 |
D |
$66.56 |
$36,408 |
D/D |
(547) |
14,498 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2021-03-10 |
4 |
D |
$60.93 |
$162,196 |
D/D |
(2,662) |
13,976 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,045 |
15,514 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,483 |
14,717 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2021-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(60) |
9,092 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2020-09-01 |
4 |
D |
$60.97 |
$13,413 |
D/D |
(220) |
8,170 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2020-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
642 |
8,390 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2020-07-01 |
4 |
D |
$59.43 |
$21,811 |
D/D |
(367) |
7,748 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & Controller |
• – – |
2020-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,069 |
8,115 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$116,845 |
D/D |
(2,017) |
7,046 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
552 |
8,025 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,063 |
7,778 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(39) |
4,649 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2019-09-01 |
4 |
D |
$48.07 |
$10,575 |
D/D |
(220) |
3,487 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2019-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
641 |
3,707 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2019-05-16 |
4 |
S |
$47.56 |
$145,771 |
D/D |
(3,065) |
3,066 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(335) |
4,927 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Controller |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,825 |
6,850 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
